Business Details
50+ Years
experience
Your Trusted Partner for Genetic Research & Precision Medicine Solutions
Jacksonville Public Housing is a nonprofit biomedical research institution dedicated to improving human health through groundbreaking genetic and genomic research. Founded nearly a century ago, we have pioneered the use of mouse models to understand human disease, combining this expertise with cutting-edge stem cell technologies and AI-powered data analysis to accelerate biomedical discovery. Our collaborative research centers focus on complex diseases such as cancer, aging, neurodegeneration, and addiction, while our educational programs provide training for scientists and clinicians worldwide.We maintain rigorous scientific standards through state-of-the-art core services and extensive genomic databases, ensuring researchers have access to the most sophisticated tools and resources. Our mission-driven approach emphasizes open data sharing and partnerships, including our recent integration with the New York Stem Cell Foundation to create the JAX-NYSCF Collaborative. With a global impact spanning preclinical drug development, precision medicine, and rare disease research, we remain committed to translating laboratory discoveries into clinical applications that benefit patients.
Services
Genetic Research
Mouse Models
Stem Cell Research
AI Data Analysis
Drug Development
Genomic Databases
Educational Programs
Precision Medicine
Rare Disease Research
Preclinical Services
Details
- Year established: 1929
Highlights and features
- We combine 90+ years of mouse genetics expertise with AI and stem cell innovations
- Our nonprofit mission prioritizes open scientific collaboration over commercial interests
- We maintain the world's most comprehensive mouse model repository for research
- Our educational programs train thousands of scientists annually across all career stages
- We lead national initiatives like MorPhiC to decode human gene function at scale
Services
Genetic Research
Our genetic research programs investigate the molecular basis of complex diseases through mouse models and human genomic data. We focus on cancer, neurodegeneration, aging, and metabolic disorders, employing advanced sequencing technologies and computational analysis. Our work bridges basic discovery with clinical translation to develop precision therapies.
Mouse Models
We develop and maintain the world's most comprehensive collection of genetically defined mouse strains for biomedical research. These models enable preclinical studies of human diseases and drug responses. Our services include custom model generation, colony management, and phenotyping platforms to support drug discovery programs globally.
Stem Cell Research
Through the JAX-NYSCF Collaborative, we combine stem cell technologies with mouse genetics to model human diseases. Our research creates patient-derived cellular models for drug screening and develops regenerative medicine approaches. We focus on neurodegenerative diseases, diabetes, and rare genetic disorders using cutting-edge iPSC technologies.
AI Data Analysis
Our data science initiatives apply AI and machine learning to large-scale genomic datasets. We develop predictive models for disease mechanisms and drug responses through projects like MorPhiC, which aims to characterize all human genes. Our computational tools enhance drug target identification and accelerate therapeutic development.
Educational Programs
We offer comprehensive educational resources for scientists at all career stages, including hands-on courses, virtual learning modules, and mentored research opportunities. Our programs cover genetics, genomics, and precision medicine, training thousands of researchers annually through both in-person and online platforms.
People
Lon Cardon
President and CEO
Dr. Lon Cardon is a renowned human geneticist with extensive leadership experience in academic and industry research. He oversees JAX's strategic vision for integrating mouse genetics, stem cell research, and AI-driven discovery to advance precision medicine.
Joan Alexander
Chief Research Officer
Dr. Joan Alexander leads JAX's research enterprise, overseeing centers focused on cancer, aging, and neurodegenerative diseases. With expertise in molecular genetics, she directs programs that translate basic discoveries into clinical applications through collaborative partnerships.
Questions
What makes JAX mouse models unique for research?
JAX maintains the largest collection of genetically characterized mouse strains with extensive phenotypic data, enabling precise disease modeling and drug testing.
How does JAX contribute to precision medicine?
We integrate mouse genetics, human genomics, and AI analysis to identify disease mechanisms and develop targeted therapies tailored to individual genetic profiles.
What educational resources does JAX offer?
We provide hands-on courses, virtual learning modules, and mentored research programs for scientists at all career stages, focusing on genetics and genomics applications.
How does the JAX-NYSCF collaboration advance research?
This partnership combines mouse genetics expertise with stem cell technologies to create more accurate disease models and accelerate drug discovery for complex conditions.
What research areas does JAX prioritize?
We focus on cancer, aging, neurodegeneration, addiction, and rare diseases through interdisciplinary centers that integrate genomic technologies and computational approaches.
Videos
